← Eichor
Study identifier: NCT03434392 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

Condition: Chronic Pancreatitis · Chronic Pain  ·  Sponsor: Anna Evans Phillips

PhaseNA
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Quantitative Sensory Testing (QST) is a novel investigative technique used in other pain conditions to evaluate patterns of chronic pain, and in this study will be used to elucidate pain patterns in patients with Chronic Pancreatitis (CP). QST uses a specific series of standardized stimulations to map the pain system. QST has the potential to change and improve the treatment paradigm for patients with CP and may eventually be able to predict response to invasive CP therapies.

This description comes directly from the study's public registry record.

Talk to the study team

Anna Evans-Phillips, MD  ·  412-624-4560  ·  evansac3@upmc.edu

Apsara Mishra  ·  apm179@pitt.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Johns Hopkins Medical InstitutionsBaltimore, Maryland, United StatesRecruiting
University of Pittsburgh Medical CenterPittsburgh, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03434392